First Pharmaceutical announced that revenue for the first half of 2026 was 982 million yuan, a year-on-year decrease of 1.51%; net profit attributable to shareholders of listed companies was 26.1698 million yuan, an increase of 86.60% over the same period in 2025; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 1,311,900 yuan, a year-on-year decrease of 85.44%.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.